TDC
AXGN icon

Thompson Davis & Co’s Axogen AXGN Stock Holding History

Thompson Davis & Co’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-125
Closed -$5K – 668
2018
Q1 		$5K Buy
+125
New +$3.83K 0.01% 474
2017
Q4 		– Sell
-6,500
Closed -$126K – 707
2017
Q3 		$126K Sell
6,500
-250
-4% -$4.2K 0.22% 102
2017
Q2 		$113K Buy
6,750
+5,750
+575% +$77.5K 0.18% 114
2017
Q1 		$10K Sell
1,000
-250
-20% -$2.55K 0.01% 679
2016
Q4 		$11K Sell
1,250
-7,150
-85% -$61.6K 0.02% 665
2016
Q3 		$76K Buy
8,400
+1,550
+23% +$12.6K 0.13% 172
2016
Q2 		$47K Buy
+6,850
New +$38.7K 0.08% 254

Other funds holding AXGN

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Thompson Davis & Co's AXGN Position: Q2 2018 in Review

Thompson Davis & Co sold out of Axogen (AXGN) in Q2 2018, closing a stake of 125 shares — an estimated $5K sold.

Thompson Davis & Co first reported a position in AXGN in Q2 2016 and held it in 7 quarters. The position peaked at $126K in Q3 2017. 177 funds tracked by Wall St. Rank hold AXGN as of Q2 2018.

  • Thompson Davis & Co reported no remaining Axogen position as of Q2 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 125 Axogen shares in Q2 2018, an estimated $5K.
  • Thompson Davis & Co first reported a position in Axogen in Q2 2016 and held it in 7 quarters.
  • Thompson Davis & Co's Axogen position peaked at $126K in Q3 2017.
  • 177 funds tracked by Wall St. Rank held Axogen as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.